An analogy between the evolution of drug resistance in bacterial communities and malignant tissues

Nature Reviews Cancer

Volumn 11, Issue 5, 2011, Pages 375-382

  Lambert, Guillaume ^a   Estévez Salmeron, Luis ^b   Oh, Steve ^b   Liao, David ^b   Emerson, Beverly M ^c   Tlsty, Thea D ^b   Austin, Robert H ^a  

^a PRINCETON UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOFILM; CANCER TISSUE; CELL COMMUNICATION; CELL POPULATION; CELL STRESS; DRUG RESISTANCE; EVOLUTION; HUMAN; MICROBIAL COMMUNITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; STROMA; TUMOR CELL;

ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS;

EID: 79955448477     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc3039     Document Type: Review

References (89)

1. Hanahan, D. & Weinberg, R.A. The hallmarks of cancer. Cell 100, 57-70 (2000). (Pubitemid 30046295)
2. Ellis, L.M. & Hicklin, D.J. VEGF-targeted therapy: mechanisms of anti-tumour activity. Nature Rev. Cancer 8, 579-591 (2008).
3. Weinstein, I.B. & Joe, A. Oncogene addiction. Cancer Res. 68, 3077-3080 (2008).
4. Letai, A.G. Diagnosing and exploiting cancer's addiction to blocks in apoptosis. Nature Rev. Cancer 8, 121-132 (2008). (Pubitemid 351161322)
5. Kamb, A., Wee, S. & Lengauer, C. Why is cancer drug discovery so difficult? Nature Rev. Drug Discov. 6, 115-120 (2007). (Pubitemid 46745339)
6. Lage, H. An overview of cancer multidrug resistance: a still unsolved problem. Cell. Mol. Life Sci. 65, 3145-3167 (2008).
7. Butler, M.T., Wang, Q. & Harshey, R.M. Cell density and mobility protect swarming bacteria against antibiotics. Proc. Natl Acad. Sci. USA 107, 3776-3781 (2010).
8. Ahmed, N., Abubaker, K., Findlay, J. & Quinn, M. Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer. Curr. Cancer Drug Targets 10, 268-278 (2010).
9. Stewart, P.S. & Costerton, J.W. Antibiotic resistance of bacteria in biofilms. Lancet 358, 135-138 (2001). (Pubitemid 32709857)
10. Tong, R.T. et al. Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors. Cancer Res. 64, 3731-3736 (2004). (Pubitemid 38697278)
11. Bock, K.D., Cauwenberghs, S. & Carmeliet, P. Vessel abnormalization: another hallmark of cancer? Molecular mechanisms and therapeutic implications. Curr. Opin. Genet. Dev. 21, 73-79 (2011).
12. Balaban, N.Q., Merrin, J., Chait, R., Kowalik, L. & Leibler, S. Bacterial persistence as a phenotypic switch. Science 305, 1622-1625 (2004). (Pubitemid 39296357)
13. Sharma, S.V. et al. A Chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 141, 69-80 (2010).
14. Alonso, A., Campanario, E. & Martinez, J.L. Emergence of multidrug-resistant mutants is increased under antibiotic selective pressure in Pseudomonas aeruginosa. Microbiology 145, 2857-2862 (1999). (Pubitemid 29485900)
15. Cirz, R.T. et al. Inhibition of mutation and combating the evolution of antibiotic resistance. PLoS Biol. 3, e176 (2005).
16. Schimke, R., Kaufman, R., Alt, F. & Kellems, R. Gene amplification and drug resistance in cultured murine cells. Science 202, 1051-1055 (1978).
17. Longley, D.B. & Johnston, P.G. Molecular mechanisms of drug resistance. J.Pathol. 205, 275-292 (2005). (Pubitemid 40227997)
18. Sniegowski, P.D. & Murphy, H.A. Evolvability. Curr. Biol. 16, R831-R834 (2006). (Pubitemid 44486774)
19. Bielas, J.H., Loeb, K.R., Rubin, B.P., True, L.D. & Loeb, L.A. Human cancers express a mutator phenotype. Proc. Natl Acad. Sci. USA 103, 18238-18242 (2006). (Pubitemid 44871642)
20. Bjedov, I. et al. Stress-induced mutagenesis in bacteria. Science 300, 1404-1409 (2003). (Pubitemid 36638154)
21. Earl, D.J. & Deem, M.W. Evolvability is a selectable trait. Proc. Natl Acad. Sci. USA 101, 11531-11536 (2004). (Pubitemid 39095330)
22. Draghi, J.A., Parsons, T.L., Wagner, G.P. & Plotkin, J.B. Mutational robustness can facilitate adaptation. Nature 463, 353-355 (2010).
23. Sniegowski, P.D., Gerrish, P.J. & Lenski, R.E. Evolution of high mutation rates in experimental populations of, E.coli. Nature 387, 703-705 (1997).
24. Giraud, A. et al. Costs and benefits of high mutation rates: adaptive evolution of bacteria in the mouse gut. Science 291, 2606-2608 (2001). (Pubitemid 32249685)
25. Ponder, R.G., Fonville, N.C. & Rosenberg, S.M. A switch from high-fidelity to error-prone DNA double-strand break repair underlies stress-induced mutation. Mol. Cell 19, 791-804 (2005). (Pubitemid 41316673)
26. Gonzalez, C. et al. Mutability and importance of a hypermutable cell subpopulation that produces stress-induced mutants in Escherichia coli. PLoS Genet. 4, e1000208 (2008).
27. Drlica, K. & Zhao, X. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol. Mol. Biol. Rev. 61, 377-392 (1997). (Pubitemid 28090230)
28. Viswanathan, A., You, H. & Doetsch, P. Phenotypic change caused by transcriptional bypass of uracil in nondividing cells. Science 284, 159-162 (1999). (Pubitemid 29282072)
29. Lengauer, C., Kinzler, K.W. & Vogelstein, B. Genetic instabilities in human cancers. Nature 396, 643-649 (1998). (Pubitemid 29003936)
30. Saxowsky, T.T., Meadows, K.L., Klungland, A. & Doetsch, P.W. 8-oxoguanine-mediated transcriptional mutagenesis causes ras activation in mammalian cells. Proc. Natl Acad. Sci. USA 105, 18877-18882 (2008).
31. Ma, L. et al. Assembly and development of the Pseudomonas aeruginosa biofilm matrix. PLoS Pathog. 5, e1000354 (2009).
32. Stewart, P.S. Diffusion in biofilms. J.Bacteriol. 185, 1485-1491 (2003). (Pubitemid 36245948)
33. Rani, S.A. et al. Spatial patterns of DNA replication, protein synthesis, and oxygen concentration within bacterial biofilms reveal diverse physiological states. J.Bacteriol. 189, 4223-4233 (2007). (Pubitemid 46847371)
34. Driffield, K., Miller, K., Bostock, J.M., O.'Neill, A.J. & Chopra, I. Increased mutability of Pseudomonas aeruginosa in biofilms. J.Antimicrob. Chemother. 61, 1053-1056 (2008). (Pubitemid 351524449)
35. Oliver, A., Canton, R., Campo, P., Baquero, F. & Blazquez, J. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288, 1251-1253 (2000). (Pubitemid 30367204)
36. Boles, B.R. & Singh, P.K. Endogenous oxidative stress produces diversity and adaptability in biofilm communities. Proc. Natl Acad. Sci. USA 105, 12503-12508 (2008).
37. Macia, M.D. et al. Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections. Antimicrob. Agents Chemother. 49, 3382-3386 (2005).
38. Taddei, F. et al. Role of mutator alleles in adaptive evolution. Nature 387, 700-702 (1997).
39. Liotta, L.A. & Kohn, E.C. The microenvironment of the tumour-host interface. Nature 411, 375-379 (2001).
40. Joyce, J.A. & Pollard, J.W. Microenvironmental regulation of metastasis. Nature Rev. Cancer 9, 239-252 (2009).
41. Kalluri, R. & Zeisberg, M. Fibroblasts in cancer. Nature Rev. Cancer 6, 392-401 (2006).
42. Sethi, T. et al. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance invivo. Nature Med. 5, 662-668 (1999). (Pubitemid 29289430)
43. Rintoul, R. & Sethi, T. Extracellular matrix regulation of drug resistance in small-cell lung cancer. Clin. Sci. 102, 417-424 (2002). (Pubitemid 34275794)
44. Tredan, O., Galmarini, C.M., Patel, K. & Tannock, I.F. Drug resistance and the solid tumor microenvironment. J.Natl Cancer Inst. 99, 1441-1454 (2007).
45. Gatenby, R.A. & Gillies, R.J. Why do cancers have high aerobic glycolysis? Nature Rev. Cancer 4, 891-899 (2004). (Pubitemid 39472955)
46. Tlsty, T.D. & Coussens, L.M. Tumor stroma and regulation of cancer development. Annu. Rev. Pathol. 1, 119-150 (2006).
47. Koukourakis, M.I., Giatromanolaki, A., Harris, A.L. & Sivridis, E. Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. Cancer Res. 66, 632-637 (2006). (Pubitemid 43165922)
48. Kansal, A.R., Torquato, S., Chiocca, E.A. & Deisboeck, T.S. Emergence of a subpopulation in a computational model of tumor growth. J.Theoret. Biol. 207, 431-441 (2000).
49. Bellomo, N., Li, N. & Maini, P. On the foundations of cancer modelling: selected topics, speculations, and perspectives. Math. Models Meth. Appl. Sci. 18, 593-646 (2008). (Pubitemid 351730142)
50. Kim, M. et al. Tumor self-seeding by circulating cancer cells. Cell 139, 1315-1326 (2009).
51. Tourovskaia, A., Figueroa-Masot, X. & Folch, A. Differentiation-on-a- chip: a microfluidic platform for long-term cell culture studies. Lab. Chip 5, 14-19 (2005). (Pubitemid 40139334)
52. Kimura, H., Yamamoto, T., Sakai, H., Sakai, Y. & Fujii, T. An integrated microfluidic system for long-term perfusion culture and on-line monitoring of intestinal tissue models. Lab. Chip 8, 741-746 (2008). (Pubitemid 351585451)
53. Liu, L. et al. A microfluidic device for continuous cancer cell culture and passage with hydrodynamic forces. Lab. Chip 10, 1807-1813 (2010).
54. Groisman, A. et al. A microfluidic chemostat for experiments with bacterial and yeast cells. Nature Meth. 2, 685-689 (2005). (Pubitemid 41223095)
55. Balagadde, F.K., You, L., Hansen, C.L., Arnold, F.H. & Quake, S.R. Long-term monitoring of bacteria undergoing programmed population control in a microchemostat. Science 309, 137-140 (2005). (Pubitemid 40934993)
56. Austin, R.H., Tung, C.K., Lambert, G., Liao, D. & Gong, X. An introduction to micro-ecology patches. Chem. Soc. Rev. 39, 1049-1059 (2010).
57. Hermsen, R. & Hwa, T. Sources and sinks: a stochastic model of evolution in heterogeneous environments. Phys. Rev. Lett. 105, 248104 (2010).
58. Maley, C.C. et al. The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma. Cancer Res. 64, 7629-7633 (2004). (Pubitemid 39372110)
59. Maley, C.C. et al. Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nature Genet. 38, 468-473 (2006).
60. Conibear, T.C.R., Collins, S.L. & Webb, J.S. Role of mutation in Pseudomonas aeruginosa biofilm development. PLoS ONE 4, e6289 (2009).
61. West, S.A., Griffin, A.S., Gardner, A. & Diggle, S.P. Social evolution theory for microorganisms. Nature Rev. Microbiol. 4, 597-607 (2006). (Pubitemid 44317022)
62. Lee, H.H., Molla, M.N., Cantor, C.R. & Collins, J.J. Bacterial charity work leads to population-wide resistance. Nature 467, 82-85 (2010).
63. Fordyce, C. et al. DNA damage drives an activin A-dependent induction of cyclooxygenase?2 in premalignant cells and lesions. Cancer Prev. Res. 3, 190-201 (2010).
64. Hickson, J. et al. Societal interactions in ovarian cancer metastasis: a quorum-sensing hypothesis. Clin. Exp. Metastasis 26, 67-76 (2008).
65. Miller, M.B. & Bassler, B.L. Quorum sensing in bacteria. Annu. Rev. Microbiol. 55, 165-199 (2001). (Pubitemid 32978104)
66. Smith, J.M. Evolution and the Theory of Games 1st edn (Cambridge Univ. Press, Cambridge, UK,1982).
67. Hahn, W.C. & Weinberg, R.A. Modelling the molecular circuitry of cancer. Nature Rev. Cancer 2, 331-341 (2002). (Pubitemid 37328946)
68. Loewen, P.C. & Hengge-Aronis, R. The role of the sigma factor sigmas (KatF) in bacterial global regulation. Annu. Rev. Microbiol. 48, 53-80 (1994).
69. Zambrano, M., Siegele, D., Almiron, M., Tormo, A. & Kolter, R. Microbial competition: Escherichia coli mutants that take over stationary phase cultures. Science 259, 1757-1760 (1993). (Pubitemid 23114663)
70. Keymer, J.E., Galajda, P., Lambert, G., Liao, D. & Austin, R.H. Computation of mutual fitness by competing bacteria. Proc. Natl Acad. Sci. USA 105, 20269-20273 (2008).
71. Feist, A.M., Herrgard, M.J., Thiele, I., Reed, J.L. & Palsson, B.O. Reconstruction of biochemical networks in microorganisms. Nature Rev. Microbiol. 7, 129-143 (2009).
72. Lewis, N.E. et al. Large-scale insilico modeling of metabolic interactions between cell types in the human brain. Nature Biotech. 28, 1279-1285 (2010).
73. Moynahan, M.E., Chiu, J.W., Koller, B.H. & Jasin, M. Brca1 controls homology-directed DNA repair. Mol. Cell 4, 511-518 (1999). (Pubitemid 29531131)
74. Walker, G.C. Inducible DNA repair systems. Annu. Rev. Biochem. 54, 425-457 (1985). (Pubitemid 15073653)
75. Fernández De Henestrosa, A.R. et al. Identification of additional genes belonging to the LexA regulon in Escherichia coli. Mol. Microbiol. 35, 1560-1572 (2000).
76. Goodman, M.F. Error-prone repair, DNA polymerases in prokaryotes and eukaryotes. Annu. Rev. Biochem. 71, 17-50 (2002). (Pubitemid 34800213)
77. Hicks, W.M., Kim, M. & Haber, J.E. Increased mutagenesis and unique mutation signature associated with mitotic gene conversion. Science 329, 82-85 (2010).
78. Oliver, A. & Mena, A. Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance. Clin. Microbiol. Infect. 16, 798-808 (2010).
79. Jensen, R.B., Carreira, A. & Kowalczykowski, S.C. Purified human BRCA2 stimulates RAD51-mediated recombination. Nature 467, 678-683 (2010).
80. Patel, K.J. et al. Involvement of Brca2 in DNA repair. Mol. Cell 1, 347-357 (1998). (Pubitemid 128378883)
81. Roca, A. & Cox, M. RecA protein: structure, function, and role in recombinational DNA repair. Prog. Nucleic Acid Res. Mol. Biol. 56, 129-223 (1997).
82. Levine, A.J. p53, the cellular gatekeeper for growth and division. Cell 88, 323-331 (1997). (Pubitemid 27131374)
83. Hollstein, M. et al. Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res. 22, 3551-3555 (1994). (Pubitemid 24299821)
84. Branda, S.S., Vik, A., Friedman, L. & Kolter, R. Biofilms: the matrix revisited. Trends Microbiol. 13, 20-26 (2005). (Pubitemid 40082393)
85. Monds, R.D. & O.'Toole, G.A. The developmental model of microbial biofilms: ten years of a paradigm up for review. Trends Microbiol. 17, 73-87 (2009).
86. Stewart, P.S. & Franklin, M.J. Physiological heterogeneity in biofilms. Nature Rev. Microbiol. 6, 199-210 (2008). (Pubitemid 351256315)
87. Costerton, J.W., Stewart, P.S. & Greenberg, E.P. Bacterial biofilms: a common cause of persistent infections. Science 284, 1318-1322 (1999). (Pubitemid 29289651)
88. Donlan, R.M. & Costerton, J.W. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15, 167-193 (2002). (Pubitemid 34303762)
89. Stoodley, P. et al. Growth and detachment of cell clusters from mature mixed-species biofilms. Appl. Environ. Microbiol. 67, 5608-5613 (2001). (Pubitemid 33640996)